tradingkey.logo

Sharps Technology Inc

STSS

8.160USD

+0.070+0.87%
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
8.35MCap. mercado
PérdidaP/E TTM

Sharps Technology Inc

8.160

+0.070+0.87%
Más Datos de Sharps Technology Inc Compañía
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Información de la empresa
Símbolo de cotizaciónSTSS
Nombre de la empresaSharps Technology Inc
Fecha de salida a bolsaApr 14, 2022
Director ejecutivoMr. Robert M. Hayes
Número de empleados5
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 14
Dirección105 Maxess Road
CiudadMELVILLE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal11747
Teléfono15162464000
Sitio Webhttps://sharpstechnology.com/
Símbolo de cotizaciónSTSS
Fecha de salida a bolsaApr 14, 2022
Director ejecutivoMr. Robert M. Hayes
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
80.00K
--
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
80.00K
--
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Ruemler (Timothy James)
0.08%
The Vanguard Group, Inc.
0.05%
Otro
99.87%
Accionistas
Accionistas
Proporción
Ruemler (Timothy James)
0.08%
The Vanguard Group, Inc.
0.05%
Otro
99.87%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
0.08%
Investment Advisor
0.06%
Hedge Fund
0.01%
Otro
99.85%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
33
49.45K
5.94%
+26.45K
2025Q1
39
63.33K
6.22%
+60.72K
2024Q4
33
355.71K
5.82%
+134.96K
2024Q3
33
124.60K
7.17%
-86.28K
2024Q2
32
148.09K
20.99%
+9.96K
2024Q1
27
169.97K
24.07%
+27.63K
2023Q4
28
254.51K
44.37%
+113.61K
2023Q3
28
231.44K
42.60%
+113.95K
2023Q2
25
178.16K
37.74%
+63.93K
2023Q1
22
188.29K
39.65%
+90.30K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Ruemler (Timothy James)
161.00
0.02%
--
--
Mar 27, 2025
UBS Financial Services, Inc.
33.00
0%
+33.00
--
Mar 31, 2025
Bigger Capital Funds, LP
1.32K
0.13%
+1.32K
--
Jan 28, 2025
Hayes (Robert Michael)
448.00
0.04%
-166.00
-27.04%
Mar 31, 2025
District 2 Capital LP
434.00
0.04%
+434.00
--
Jan 28, 2025
Empery Asset Management, L.P.
119.00
0.01%
-68.00
-36.36%
Sep 30, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Fecha
Tipo
Relación
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
KeyAI